DOI 10.13107/jocr.2025.v15.i11.6388
Comparative Effectiveness of Aspirin and Low-molecular-weight heparin for Venous Thromboembolism Prophylaxis after Total Hip Arthroplasty.
Аннотация
INTRODUCTION
Total hip arthroplasty (THA) carries a persistent risk of venous thromboembolism (VTE). Contemporary guidelines endorse combined mechanical and pharmacologic prophylaxis often extended to 35 days post-operative; yet the optimal agent remains debated as evidence comparing aspirin with low-molecular-weight heparin (LMWH) is mixed (e.g., EPCAT II vs. CRISTAL).
MATERIALS AND
METHODS
We conducted a retrospective, propensity-matched cohort study using the TriNetX Network. Adults undergoing primary THA were assigned to mutually exclusive cohorts based on initial post-operative chemoprophylaxis within 7 days: Aspirin (no LMWH exposure in days 0-7) or LMWH (no aspirin exposure in days 0-7). Outcomes were assessed from post-operative day 1 to day 365. One-to-one propensity score matching balanced age, sex, race/ethnicity, body mass index, hypertension, ischemic heart disease, heart failure, diabetes, obesity, and metabolic disorders. Effect measures included risk difference (RD) with two-sided P (primary; also applied to risk ratio [RR] per protocol), (RR, 95% confidence interval [CI]), and hazard ratio (HR) from Kaplan-Meier analysis with log-rank P. Statistical significance was set at P < 0.05. Guideline context is provided for interpretability.
RESULTS
After matching (aspirin n = 8,559; LMWH n = 8,559), 1-year outcomes favored aspirin for thromboembolism. Any VTE: 1.7% versus 2.6%; RR = 0.649 (0.525-0.803), P < 0.001; and HR = 0.635, P = 0.475. Deep vein thrombosis: 1.4% versus 2.3%; RR = 0.610 (0.485-0.769), P < 0.001; and HR = 0.598, P = 0.142. Pulmonary embolism (PE): 0.6% versus 1.0%; RR = 0.665 (0.472-0.935), P = 0.018; and HR = 0.651, P = 0.603. Major bleeding: 11.1% versus 10.2%; RR = 1.089 (0.999-1.188), P = 0.053; and HR = 1.094, P = 0.001. Minor bleeding: 2.2% versus 2.1%; RR = 1.050 (0.858-1.284), P = 0.637; and HR = 1.029, P = 0.969. Emergency department visit: 13.6% versus 18.7%; RR = 0.727 (0.679-0.780), P < 0.001; and HR = 0.694, P = 0.463. Findings align with guidance permitting aspirin as prophylaxis in appropriately selected arthroplasty patients, while acknowledging randomized evidence favoring LMWH in some settings.
CONCLUSIONS
In matched THA patients, aspirin achieved lower 1-year VTE than LMWH with no statistically significant increase in major bleeding by RD. Given trial heterogeneity (e.g., CRISTAL versus meta-analyses and step-down strategies), agent selection should be individualized, balancing thrombotic and bleeding risks, logistics, and patient preference within guideline-concordant, extended prophylaxis pathways (Two-sided significance threshold: P < 0.05).
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.